Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organon & Co. (NY: OGN )

20.88 +0.31 (+1.51%)
Streaming Delayed Price Updated: 11:15 AM EDT, May 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organon & Co.

< Previous 1 2 3 4 5 6 7 8 Next >
Looking Into Organon's Recent Short Interest
Via Benzinga
Beat Inflation With These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Why Organon & Co. Stock Popped Today
Organon & Co. (NYSE: OGN) shares traded higher on Wednesday after the company announced the availability of XACIATO 2% by prescription. 
Via Benzinga
Organon’s XACIATO™ (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial Vaginosis (BV) in Females Aged 12 and Older
From Organon & Co.
Via Business Wire
Merck, the Dow's hottest stock, gets set to report Q4 financials
Up 5.7% year-to-date, pharmaceuticals - including MRK - are the best performing industry in the entire U.S. equity market, outpacing even biotech stocks. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Analyst Expectations for Organon's Future
Via Benzinga
Organon: Dividend Insights
Via Benzinga
Analyst Ratings for Organon
Via Benzinga
Organon affirms 2023 revenue and Adjusted EBITDA guidance and provides 2024 outlook
From Organon & Co.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Minutes To Boost Your Earnings: 3 Stocks With Over 3% Dividend Yields In Health Care Sector From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Organon To Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Organon & Co.
Via Business Wire
Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines
From Organon & Co.
Via Business Wire
Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Unleashing Growth Potential: Johnson &amp; Johnson Surpasses Expectations with Strong Performance and Increasing Profits
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
Is This Healthcare Stock's 10% Yield a Steal of a Deal or Too Good to Be True?
High-yielding stocks may be tantalizing, but they often come with risks. 
Via The Motley Fool
Organon To Present at the Piper Sandler 35th Annual Healthcare Conference
From Organon & Co.
Via Business Wire
Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Samsung Bioepis & Organon Announce FDA Acceptance of Supplemental Biologics License Application (sBLA) for Interchangeability Designation for HADLIMA™ (adalimumab-bwwd), a Biosimilar to Humira®
From Samsung Bioepis
Via GlobeNewswire
Organon Reports Results for the Third Quarter Ended September 30, 2023
From Organon & Co.
Via Business Wire
Organon and Sempre Health Announce Collaboration on New Service to Help Eligible Patients Save Money and Stay on Their Medication as Prescribed
From Organon & Co.
Via Business Wire
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Organon To Report Third Quarter Results and Host Conference Call on November 2, 2023
From Organon & Co.
Via Business Wire
Lululemon Athletica Races to New High with S&P 500 Entry
Lululemon's stock soared 10.31%, its best level since late 2021, upon joining the S&P 500, replacing Activision Blizzard. The change is effective October 18. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Lululemon Athletica To Join S&P 500 Index; LULU Stock Flashes Buy Signal
The yoga retailer will join the index before Wednesday's open. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Organon Recognized on Fortune’s 2023 Change the World List for Leadership in Expanding Access to Contraceptive Choice
From Organon & Co.
Via Business Wire
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.